<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">Vascular disorders</z:e> have been implicated in <z:hpo ids='HP_0000726'>dementia</z:hpo>, but whether <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is related to the most frequent type of <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, is not known </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi>-E genotype has been associated with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and we postulate that it plays a part, together with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, in the aetiology of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the frequency of <z:hpo ids='HP_0000726'>dementia</z:hpo> and its subtypes in relation to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We did a population-based study of 284 patients with <z:hpo ids='HP_0000726'>dementia</z:hpo>, 207 of whom had <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and 1698 individuals who were not <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Indicators of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> included vessel wall thickness and plaques of the carotid arteries, assessed by ultrasonography, and the ratio of ankle-to-brachial systolic blood pressure as a measure of generalised <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Based on these indicators participants were scored from 0 (no <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>) to 3 (severe <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>) for degree of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi>-E polymorphisms were assessed in 246 patients and in 928 controls </plain></SENT>
<SENT sid="7" pm="."><plain>FINDINGS: <z:hpo ids='HP_0000001'>All</z:hpo> indicators of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> were associated with <z:hpo ids='HP_0000726'>dementia</z:hpo> (odds ratios ranging from 1.3 to 1.9) and its major subtypes <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (odds ratios 1.3-1.8) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (odds ratios 1.9-3.2) </plain></SENT>
<SENT sid="8" pm="."><plain>The frequencies of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> increased with the degree of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The odds ratio for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> in those with severe <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> compared with those without <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was 3.0 (95% CI 1.5-6.0; p = 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>In participants with the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi>-E epsilon 4 genotype and an <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> score of 2 or 3 the odds ratio for <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> was 4.5 (2.0-10.1; p &lt; 0.001), for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> was 3.9 (1.6-9.6; p = 0.002), and for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> was 19.8 (4.1-95.0; p &lt; 0.001) </plain></SENT>
<SENT sid="12" pm="."><plain>INTERPRETATION: These findings suggest that <z:hpo ids='HP_0000726'>dementia</z:hpo> and its two major subtypes <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> are associated with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and that there is an interaction between <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in the aetiology of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>